AssetMark’s Phibro Animal Health PAHC Stock Holding History
Bought
Maintained
Sold
Other funds holding PAHC
AssetMark's PAHC Position: Q3 2026 in Review
AssetMark increased its Phibro Animal Health (PAHC) stake by 67% in Q3 2026, buying an estimated $141 and bringing the position to 10 shares worth $357. The position accounts for ﹤0.01% of the portfolio, ranked #3497.
AssetMark first reported a position in PAHC in Q4 2016 and has held it in 6 quarters since. The position peaked at $830 in Q1 2026. 181 funds tracked by Wall St. Rank hold PAHC as of Q3 2026.
- AssetMark held 10 shares of Phibro Animal Health worth $357 as of Q3 2026.
- AssetMark bought 4 Phibro Animal Health shares in Q3 2026, an estimated $141.
- Phibro Animal Health made up ﹤0.01% of AssetMark's portfolio in Q3 2026, its #3497 holding.
- AssetMark first reported a position in Phibro Animal Health in Q4 2016 and has held it in 6 quarters since.
- AssetMark's Phibro Animal Health position peaked at $830 in Q1 2026.
- 181 funds tracked by Wall St. Rank held Phibro Animal Health as of Q3 2026.
Based on AssetMark's 13F filing for Q3 2026, filed 21 Oct 2026.